Intravitreal tissue plasminogen activator in submacular haemorrhage.
Submacular haemorrhage is a major cause of sudden visual loss in age-related macular degeneration (AMD). If left untreated it often results in permanent central visual loss. We present our experience in the use of intravitreal tissue plasminogen activator (tPA) in a 65-year-old male with submacular haemorrhage.
Singh
P
P
Dr Sohan Singh Eye Hospital, Amritsar, India.
Singh
R
R
Kishore
K S
KS
Vig
V K
VK
Singh
R
R
Singh
B
B
D000368:Aged; D017809:Fatal Outcome; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D006801:Humans; D007267:Injections; D008266:Macula Lutea / Q000473:pathology*; D008297:Male; D010960:Plasminogen Activators / Q000627:therapeutic use*; D012166:Retinal Hemorrhage / Q000175:diagnosis / Q000188:drug therapy*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014822:Vitreous Body
D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator